tiprankstipranks
Compass Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyCompass Therapeutics downgraded to Market Perform from Outperform at Leerink
2M ago
Compass Therapeutics Reports Q3 2024 Financials and Clinical Progress
Premium
Company Announcements
Compass Therapeutics Reports Q3 2024 Financials and Clinical Progress
2M ago
Compass Therapeutics price target raised to $7 from $5 at Ladenburg
Premium
The Fly
Compass Therapeutics price target raised to $7 from $5 at Ladenburg
2M ago
Compass Therapeutics files $300M mixed securities shelf
PremiumThe FlyCompass Therapeutics files $300M mixed securities shelf
5M ago
Compass Therapeutics reports Q2 EPS (10c), consensus (9c)
Premium
The Fly
Compass Therapeutics reports Q2 EPS (10c), consensus (9c)
5M ago
Compass Therapeutics completes patient enrollment in COMPANION-002
Premium
The Fly
Compass Therapeutics completes patient enrollment in COMPANION-002
6M ago
CMPX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCMPX Upcoming Earnings Report: What to Expect?
9M ago
Compass Therapeutics receives FDA FTD for investigation of CTX-009
Premium
The Fly
Compass Therapeutics receives FDA FTD for investigation of CTX-009
9M ago
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
Premium
Company Announcements
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100